Suppr超能文献

在肾病综合征中,莫唑胺与呋塞米的比较:进一步支持存在不同载体参与肠吸收过程

Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.

作者信息

Bazzato G, Coli U, Landini S, Fracasso A, Righetto F, Scanferla F, Forte M, Morachiello P

出版信息

Z Kardiol. 1985;74 Suppl 2:92-5.

PMID:4002811
Abstract

The authors have compared during 4 weeks of study the effects of furosemide (F) by oral route or i.v. and muzolimine (M)/os in 10 patients with nephrotic syndrome (NS) and normal renal function. A satisfactory diuretic response was observed with i.v. F (100 mg) and M/os (30-60 mg) with respect to the basal condition (P less than 0.001), while F/os (100 mg) was ineffective in these patients. This behaviour may be explained by the different pharmacological properties of M vs. F, by gut alterations due to the oedema of mucosa or loss of some "carrier(s)" operating for intestinal absorption of these two high ceiling diuretics.

摘要

作者在为期4周的研究中,比较了静脉注射和口服速尿(F)以及口服莫唑胺(M)对10例肾功能正常的肾病综合征(NS)患者的影响。静脉注射F(100mg)和口服M(30 - 60mg)相对于基础状态观察到了满意的利尿反应(P < 0.001),而口服F(100mg)对这些患者无效。这种情况可能是由于M与F不同的药理特性,以及黏膜水肿导致的肠道改变或这两种高效能利尿剂肠道吸收所需的某些“载体”丢失所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验